Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Exploring Inner Choroidal Flow Deficits Across the Different Stages of Dry Age-related Macular Degeneration: Insights from Swept-Source OCT Angiography and Associations with Structural Biomarkers.
Author Affiliations & Notes
  • Katherine M Overbey
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Francesco Romano
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Cade F Bennett
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Xinyi Ding
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Isabella Stettler
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ioanna Ploumi
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Itika Garg
    Tulane University School of Medicine, New Orleans, Louisiana, United States
  • Filippos Vingopoulos
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Rodrigo Alvarez
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Peyman Razavi
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Leo A Kim
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • David M Wu
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Deeba Husain
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Demetrios G. Vavvas
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Joan W Miller
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • John B Miller
    Retina, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Katherine Overbey None; Francesco Romano None; Cade Bennett None; Xinyi Ding None; Isabella Stettler None; Ioanna Ploumi None; Itika Garg None; Filippos Vingopoulos None; Rodrigo Alvarez None; Peyman Razavi None; Leo Kim Massachusetts Eye and Ear (11229662 and WO2019099595), Code P (Patent); David Wu Massachusetts Eye and Ear, Code P (Patent); Deeba Husain Genentech, Allergan, Novartis, Omeicos Therapeutics, Code C (Consultant/Contractor), NIH, National Eye Institute, Lions Vision Gift, Commonwealth Grant, Lions International, Syneos LLC, the Macular Society, Code F (Financial Support); Demetrios Vavvas TwentyTwenty, Sumitomo/Sunovion, Cambridge Polymer Group, Olix Pharma, Valitor, Code C (Consultant/Contractor), NIH, National Eye Institute, Research to Prevent Blindness, Loefflers Family Foundation, Yeatts Family Foundation, Alcon Research Institute, Code F (Financial Support), Drusolv Therapeutics, Code O (Owner), Massachusetts Eye and Ear, Code P (Patent); Joan Miller Sunovion, Genentech/ Roche, KalVista Pharmaceuticals, ONL Therapeutics, Heidelberg Engineering, Code C (Consultant/Contractor), Lowy Medical Research Institute, National Eye Institute, Heidelberg Engineering , Code F (Financial Support), Ciendias Bio, Code I (Personal Financial Interest), Drusolv Therapeutics, ONL Therapeutics, Valeant Pharmaceuticals/Mass. Eye and Ear, Code P (Patent), Aptinyx, Inc., Sunovion, KalVista Pharmaceuticals, ONL Therapeutics, Valeant Pharmaceuticals/Mass. Eye and Ear, Code R (Recipient), Aptinyx, Inc., ONL Therapeutics, Code S (non-remunerative); John Miller Alcon, Allergan, Carl Zeiss, Sunovion, Genentech, Topcon, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2311. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Katherine M Overbey, Francesco Romano, Cade F Bennett, Xinyi Ding, Isabella Stettler, Ioanna Ploumi, Itika Garg, Filippos Vingopoulos, Rodrigo Alvarez, Peyman Razavi, Leo A Kim, David M Wu, Deeba Husain, Demetrios G. Vavvas, Joan W Miller, John B Miller; Exploring Inner Choroidal Flow Deficits Across the Different Stages of Dry Age-related Macular Degeneration: Insights from Swept-Source OCT Angiography and Associations with Structural Biomarkers.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2311.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Inner choroidal flow deficit percentage (ICFD%) is a new metric to assess choriocapillaris perfusion using optical coherence tomography angiography (OCTA). Aim of this study is to establish a reference database for ICFD% for dry age-related macular degeneration (AMD) and explore the association with other imaging biomarkers.

Methods : This observational, cross-sectional study included dry AMD eyes (Beckman classification) with good-quality 6x6-mm swept-source OCTA (PLEX® Elite 9000; Carl Zeiss Meditec).
OCTA scans were processed on ARI Network with the Choriocapillaris Slab Imaging algorithm (v.0.2). 5-25-µm compensated angio images with Max Projection were imported in FIJI (NIH), and ICFD% was measured after binarization (Phansalkar method, r=15 px) in the central 6, 3, and 1 mm circles and ETDRS sectors. Additionally, (1) scans were graded for subretinal drusenoid deposits (SSD), (2) drusen volume in the central 3 mm was collected from PLEX® Elite software, (3) size of retinal pigment epithelium (RPE) atrophy was manually measured from the hypertransmission defects slab (RPE-RPE, 64-400 offset).
The relationship between ICFD%, AMD stage, and other biomarkers was assessed using non-parametric comparison tests and generalized linear mixed-effects models after nesting and adjusting for age.

Results : Overall, 270 eyes of 181 patients (median age 74, Female 76%) were included (70 early, 121 intermediate, 79 advanced dry AMD).
ICFD% were 19.7-22.0 for early, 24.3-27.7 for intermediate, and 29.5-32.4 for dry advanced AMD. ICFD% significantly increased with AMD stage severity, SDD presence, and greater RPE atrophy in all the analyzed regions (all p<0.05). On multivariate analysis, older age and more severe AMD stage were associated with greater ICFD% in all analyzed regions (all p<0.01). More extensive RPE atrophy was associated with greater ICFD% in the 6-mm circle and outer ETDRS sectors (all p<0.05).

Conclusions : This study establishes an initial reference database for ICFD% across dry AMD stages and reports associations with characteristic AMD imaging biomarkers. Our findings show that greater choriocapillaris flow deficits are seen with aging, more advanced AMD stage, and larger RPE atrophy. ICFD% is a promising OCTA biomarker for assessing the perfusion status of choriocapillaris in AMD.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×